Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double-blind, controlled trial.
about
Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double-blind, controlled trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Antithrombin III for portal ve ...... ouble-blind, controlled trial.
@en
Antithrombin III for portal ve ...... ouble-blind, controlled trial.
@nl
type
label
Antithrombin III for portal ve ...... ouble-blind, controlled trial.
@en
Antithrombin III for portal ve ...... ouble-blind, controlled trial.
@nl
prefLabel
Antithrombin III for portal ve ...... ouble-blind, controlled trial.
@en
Antithrombin III for portal ve ...... ouble-blind, controlled trial.
@nl
P2093
P2860
P356
P1433
P1476
Antithrombin III for portal ve ...... ouble-blind, controlled trial.
@en
P2093
Hirofumi Kawanaka
Hisashi Hidaka
Kazuo Notsumata
Keiji Tsuji
NPB-06 study group
Namiki Izumi
Shigehiro Kokubu
Shingo Asahara
Shinji Katsushima
Shoichi Matsutani
P2860
P356
10.1111/HEPR.12934
P577
2017-06-30T00:00:00Z